-
Mashup Score: 5
“We found that female patients, Black patients, and patients with non-private insurance had a decreased odds of receiving opioids,” says Hailey Frye.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 15
“A key point is the supply chain is very fragile, and there’s not really a good financial incentive to make these drugs,” says Ruchika Talwar, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Ruchika Talwar, MD, (@RuchikaTalwarMD) recaps an #AUASummit25 session on the ongoing drug shortages in urology. | @VUMCurology @AmerUrological https://t.co/e0wfWC3UAQ
-
-
Mashup Score: 1The Contemporary Treatment Landscape of mCRPC - 5 day(s) ago
Panelists discuss how the evolving treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) encompasses multiple therapeutic options including novel hormonal agents, chemotherapy, and targeted therapies while highlighting persistent challenges in treatment sequencing, drug resistance, and the need for improved biomarker-driven approaches to optimize patient outcomes.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Dr. Evan Yu, Dr. Jack R. Andrews, and Dr. Jacob J. Orme discuss the evolving treatment landscape for mCRPC, focusing on therapy options, sequencing challenges, and biomarker-driven approaches. Watch now: https://t.co/0NZlMegmVS https://t.co/2Cyx9QAmZ6
-
-
Mashup Score: 1Dr Louise Kostos discusses PSA kinetics in mHSPC - 5 day(s) ago
“Personally, I think monitoring and analyzing PSA kinetics is a great one because it’s cheap and it’s readily available,” says Dr Louise Kostos.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Dr Louise Kostos (@LouiseKostos) discusses PSA kinetics in mHSPC. #pcsm https://t.co/oDDMfhAmwN
-
-
Mashup Score: 1
The study will evaluate the investigational drug product ONC175 (orellanine) in patients with metastatic clear cell or papillary renal cell carcinoma.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
The @US_FDA has approved a phase 1/2 study of ONC175 (orellanine) in patients with metastatic clear cell or papillary renal cell carcinoma. #kcsm https://t.co/HiIhEl94Yy
-
-
Mashup Score: 1Laura Bukavina, MD, on trial of radiation with concurrent sacituzumab govitecan in MIBC - 6 day(s) ago
The trial is assessing the safety and tolerability of adaptive radiation therapy with concurrent sacituzumab govitecan in patients with MIBC.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Laura Bukavina, MD, (@LauraBukavinaMD) discusses the RAD-SG trial, evaluating adaptive radiation with concurrent sacituzumab govitecan in MIBC. @CleClinicUro #blcsm https://t.co/kHe9yOYHwN
-
-
Mashup Score: 4
“The study suggests that exercise would be an effective intervention for men with prostate cancer who express concern about sexual dysfunction, and that exercise medicine should be considered a key part of their treatment,” says Daniel Galvão, PhD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Findings from a recent study suggest that regular exercise may improve erectile function in men with prostate cancer. #pcsm https://t.co/9qE3VhjN5y
-
-
Mashup Score: 1Michael R. Folkert, MD, PhD, discusses real-world outcomes with spacer in prostate cancer - 6 day(s) ago
“4 years following radiation therapy, there is a 25% lower hazard of bowel disorders and a 46% lower hazard of related procedures [in patients who received a spacer],” says Michael R. Folkert, MD, PhD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Michael R. Folkert, MD, PhD, (@DrMikeFolkert) shares real-world outcomes with spaceOAR in men with prostate cancer. @fredhutch #pcsm https://t.co/QPgMISZBMY
-
-
Mashup Score: 2What determines the optimal urinary diversion? - 6 day(s) ago
“Ultimately, there is no ‘right choice’ when it comes to urinary diversion,” writes Anne K. Schuckman, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Anne K. Schuckman, MD, (@AnneSchuckmanMD) outlines factors to help determine the optimal urinary diversion for each patient. @USC_Urology #urology https://t.co/owumt8OhDg
-
-
Mashup Score: 2
The overall prevalence of kidney stones overall remained stable, with a notable increase observed among women.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Data from a recent study show that the prevalence of kidney stones has increased among women over the past decade. #urology https://t.co/Z4EQ5arVyB
-
Hailey Frye (@HaileyHFrye) discusses study findings showing disparities in pain management for nephrolithiasis. https://t.co/4Kpn9ccKRi